Saha A R, Ueno K, Mitsuhashi H, Ohmori S, Igarashi T, Kitagawa H
Laboratory of Biochemical Pharmacology and Biotoxicology, Faculty of Pharmaceutical Sciences, Chiba University, Japan.
Res Commun Chem Pathol Pharmacol. 1987 Jul;57(1):117-27.
The immunopotentiating activity of heptaminol AMP amidate (HAA), a new derivative of 5'-AMP, was examined in experimental animals. Anti-SRBC PFC activity and antibody titer values augmented for both of single and 4 days consecutive administrations in ICR male mice. The dose of 10 mg/kg was found to cause the maximum enhancement. In spontaneously hypertensive rats, with a state of immunosuppression, 10 days consecutive administrations of HAA at the dose of 10 mg/kg was found to increase significantly the anti-SRBC PFC and antibody titer values. From these results, it is tempting to suggest that HAA may possess an immunopotentiating activity.
对5'-AMP的新衍生物庚胺醇AMP酰胺(HAA)的免疫增强活性在实验动物中进行了研究。在ICR雄性小鼠中,单次和连续4天给药后,抗SRBC PFC活性和抗体滴度值均有所增加。发现10mg/kg的剂量可引起最大增强。在处于免疫抑制状态的自发性高血压大鼠中,连续10天给予10mg/kg剂量的HAA可显著提高抗SRBC PFC和抗体滴度值。从这些结果来看,很容易推测HAA可能具有免疫增强活性。